We are live on
!
Find out more
JJ
Johnson & Johnson Portfolio holdings
AUM
$799M
Turnover
17.65%
1-Year Est. Return
253.51%
This Fund
S&P 500
This Quarter
Est. Return
-10.47%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$391M
AUM Growth
-$138M
(-26%)
Cap. Flow
$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
92.53%
Holding
22
New
–
Increased
–
Reduced
–
Closed
–
Avg Time Held
0.7
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.7
years
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Legend Biotech
LEGN
$3.7B
| $89.6M | 22.89% |
1,629,173
| – | – |
2021 Q3
3 quarters
|
|
2
Fate Therapeutics
FATE
$232M
| $83.7M | 21.39% |
3,379,064
| – | – |
2021 Q3
3 quarters
|
|
3
Arrowhead Research
ARWR
$8.25B
| $44.4M | 11.34% |
1,260,869
| – | – |
2021 Q3
3 quarters
|
|
4
Procept Biorobotics
PRCT
$1B
| $33.3M | 8.51% |
1,018,478
| – | – |
2021 Q3
3 quarters
|
|
5
MeiraGTx Holdings
MGTX
$904M
| $21.9M | 5.61% |
2,898,550
| – | – |
2021 Q3
3 quarters
|
|
6
CVRx
CVRX
$35.7M
| $21M | 5.37% |
3,495,575
| – | – |
2021 Q3
3 quarters
|
|
7
Xencor
XNCR
$1.74B
| $20.5M | 5.23% |
748,062
| – | – |
2021 Q4
2 quarters
|
|
8
Protagonist Therapeutics
PTGX
$8.82B
| $19.4M | 4.95% |
2,449,183
| – | – |
2021 Q3
3 quarters
|
|
9
DELISTED
Cue Health Inc. Common Stock
HLTH
| $17.8M | 4.54% |
5,548,864
| – | – |
2021 Q3
3 quarters
|
|
10
Adicet Bio
ACET
$45.8M
| $10.6M | 2.72% |
45,559
| – | – |
2021 Q3
3 quarters
|
|
11
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
| $9.14M | 2.33% |
3,670,516
| – | – |
2021 Q3
3 quarters
|
|
|
PNT
12
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $6.81M | 1.74% |
1,000,000
| – | – |
2021 Q3
3 quarters
|
|
13
Vor Biopharma
VOR
$1.11B
| $5.34M | 1.36% |
53,733
| – | – |
2021 Q3
3 quarters
|
|
14
Nano X Imaging
NNOX
$40.1M
| $2.17M | 0.56% |
192,429
| – | – |
2021 Q4
2 quarters
|
|
15
Aldeyra Therapeutics
ALDX
$47.7M
| $1.57M | 0.4% |
394,834
| – | – |
2021 Q3
3 quarters
|
|
|
HLSQ
16
Tessera Defense and Homeland Security Inc.
HLSQ
$2.15M
| $1.56M | 0.4% |
1,123
| – | – |
2021 Q3
3 quarters
|
|
|
SLGC
17
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $1.27M | 0.32% |
281,052
| – | – |
2021 Q3
3 quarters
|
|
|
PHAS
18
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $964K | 0.25% |
1,607,044
| – | – |
2021 Q3
3 quarters
|
|
|
TCON
19
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $168K | 0.04% |
4,200
| – | – |
2021 Q3
3 quarters
|
|
20
Gyre Therapeutics
GYRE
$686M
| $119K | 0.03% |
8,927
| – | – |
2021 Q3
3 quarters
|
|
21
Senseonics Holdings Inc
SENS
$428M
| $56K | 0.01% |
2,731
| – | – |
2021 Q3
3 quarters
|
|
22
CalciMedica
CALC
$7.31M
| $54K | 0.01% |
708
| – | – |
2021 Q3
3 quarters
|
|
Similar funds
SEM
TI
GIM
QCMNJ
LOPW
HW
CCM
LWM
Johnson & Johnson's Q2 2022 Portfolio in Review
As of Q2 2022, Johnson & Johnson held 22 positions worth $391M, down 26% from $529M the previous quarter. Its ten largest holdings account for 93% of the portfolio.
Trading was light in Q2 2022: portfolio turnover was 0%. Johnson & Johnson opened no new positions and made no exits, leaving the 22-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.
- Johnson & Johnson's ten largest holdings make up 93% of its $391M portfolio in Q2 2022.
- Johnson & Johnson opened 0 new positions and closed 0 in Q2 2022.
- Johnson & Johnson's portfolio value fell 26% quarter-over-quarter to $391M.
Based on Johnson & Johnson's 13F filing for Q2 2022, filed 10 Aug 2022.